1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6AB4DA1F4AB67193665257EF300401C3D
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-enabling-marketing-insights-superior-competitiveness-through-faster-market-research-approvals-process-excellence
18
19
203.95.23.35
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Market Research, Analytics and Forecasting Process Excellence and Productivity Management

Enabling Marketing Insights and Superior Competitiveness Through Faster Market Research Approvals: Process Excellence

ID: 5386


Features:

27 Info Graphics

12 Data Graphics

71 Metrics

21 Narratives


Pages/Slides: 50


Published: 2015


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Enabling Marketing Insights and Superior Competitiveness Through Faster Market Research Approvals: Process Excellence"

STUDY OVERVIEW

In order to gain critical market insights that can provide a competitive advantage, it is important for pharmaceutical companies to ensure timely approvals of market research studies. In today's fast-moving marketplace, biopharmaceutical companies need to develop a tactical approach that expedites the approval process for market research projects.


Best Practices, LLC undertook this benchmarking study to investigate how leading companies manage cycle times and fast responses to accelerate the market research approval process. The study provides benchmarks around approval process excellence, as well as best practices of high-performing organizations. There is also a chapter regarding a case study of how one organization improved its approval system for market research studies.



KEY TOPICS

Best Practice of High-Performing Companies
Approval Process Excellence Drivers
Best Practice Case Study: How One Company Evolved Fast & Efficient Approval Systems


KEY METRICS

Metrics for Judging Effectiveness of Market Research Approval Process
Use of Approaches for Tracking & Managing Approval Process
Use of Approaches for Preventing Promotional Language
Segmentation Used in Determining Project Urgency
Balancing Project Types & Reviews
Adverse Event Identification
Effective Education & Training


SAMPLE KEY FINDINGS

Process Simplification Commonly Used to Track and Manage MR Approval Process: All benchmark respondents take at least one approach to tracking and managing the market research approval process. Process simplification is the most common approach, always used by 75% and used "sometimes" by the remainder of companies.

METHODOLOGY

Best practices, LLC engaged 22 executives from 21 leading pharmaceutical, biotech, and life sciences companies. Eleven companies responded on behalf of rare disease markets. Eight companies participated in deep-dive interviews about the drivers of operational excellence.


Industries Profiled:
Pharmaceutical; Biotech; Manufacturing; Consumer Products; Diagnostic; Medical Device; Chemical; Health Care; Technology; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Abbvie; actavis; Amgen; AstraZeneca; Bayer; Biogen; Boehringer Ingelheim; CSL Behring; Fresenius Kabi; Genentech; Grifols; Jazz Pharmaceuticals; Lilly; NeedleTech Products Inc.; Novartis; Novo Nordisk; Philips Healthcare; Roche; Sanofi; Teva Pharmaceutical Industries Ltd; UCB Pharma


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.